DIAMETRA SRL
- Shared products
- ALDOSTERONE, ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY, ANTI-PANCREATIC ISLET CELL ANTIBODY, ANTICARDIOLIPIN, CORTISOL/CORTISONE, DEHYDROEPIANDROSTERONE SULFATE (DHEA-S), FREE TESTOSTERONE, HUMAN GROWTH HORMONE (HGH, GH OR SOMATOTROPIN), INSULIN-LIKE GROWTH FACTOR I, INTACT PARATHYROID HORMONE (iPTH), TESTOSTERONE
- Shared products
- 17-HYDROXYPROGESTERONE (17-OHP), ALDOSTERONE, CORTISOL/CORTISONE, FREE TESTOSTERONE, HUMAN GROWTH HORMONE (HGH, GH OR SOMATOTROPIN), INTACT PARATHYROID HORMONE (iPTH), TESTOSTERONE
- Shared products
- CORTISOL/CORTISONE, DEHYDROEPIANDROSTERONE SULFATE (DHEA-S), FREE TESTOSTERONE, HUMAN GROWTH HORMONE (HGH, GH OR SOMATOTROPIN), INSULIN-LIKE GROWTH FACTOR I, INTACT PARATHYROID HORMONE (iPTH), TESTOSTERONE
- Shared products
- 17-HYDROXYPROGESTERONE (17-OHP), ALDOSTERONE, DEHYDROEPIANDROSTERONE SULFATE (DHEA-S), FREE TESTOSTERONE, HUMAN GROWTH HORMONE (HGH, GH OR SOMATOTROPIN), INSULIN-LIKE GROWTH FACTOR I, TESTOSTERONE
- Shared products
- 17-HYDROXYPROGESTERONE (17-OHP), ALDOSTERONE, CORTISOL/CORTISONE, DEHYDROEPIANDROSTERONE SULFATE (DHEA-S), HUMAN GROWTH HORMONE (HGH, GH OR SOMATOTROPIN), INTACT PARATHYROID HORMONE (iPTH), TESTOSTERONE
Explore comprehensive manufacturer profile for DIAMETRA SRL based in Italy through Pure Global AI's free Brazil medical device database. This manufacturer has 16 products registered with ANVISA across 13 unique technical categories. Their regulatory history spans from Aug 17, 2009 to Jul 22, 2024.
This page provides detailed insights including 5 recent product registrations including IMMUNOGLOBULIN A SUBCLASS (IgA1/IgA2), 5 most popular products with CORTISOL/CORTISONE having 2 registrations, 2 registration holders including GOYAZES BIOTECNOLOGIA LTDA, and 5 key competitors with SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. sharing 11 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.